Ticker Details
BeyondSpring Inc. Ordinary Shares BeyondSpring Inc is engaged in clinical stage biopharmaceutical activities focused on the development of cancer therapies.
IPO Date:	March 9, 2017
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$29.61M
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.40 | 4.15%
Avg Daily Range (30 D):	$0.06 | 5.77%
Avg Daily Range (90 D):	$0.07 | 5.12%

Institutional Daily Volume
Avg Daily Volume:	.26M
Avg Daily Volume (30 D):	1.09M
Avg Daily Volume (90 D):	.38M

Trade Size
Avg Trade Size (Sh.):	151
Avg Trade Size (Sh.) (30 D):	321
Avg Trade Size (Sh.) (90 D):	309

Institutional Trades
Total Institutional Trades:	120
Avg Institutional Trade:	$1.44M
Avg Institutional Trade (30 D):	$.73M
Avg Institutional Trade (90 D):	$.73M
Avg Institutional Trade Volume:	.11M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$1.69M
Avg Closing Trade (30 D):	$.73M
Avg Closing Trade (90 D):	$.73M
Avg Closing Volume:	174.16K

News

Dec 12, 2025 @ 12:00 PM BeyondSpring Announces ESMO Asia Presentation on P... Source: Beyondspring Inc.

Jan 28, 2025 @ 12:00 PM SEED Receives FDA Rare Pediatric Disease and Orpha... Source: N/A

Jan 28, 2025 @ 12:00 PM BeyondSpring Announces $35.4 Million Sale of a Por... Source: Beyondspring Inc.

Nov 11, 2024 @ 1:00 PM BeyondSpring Presents Updated Efficacy Results fro... Source: N/A

Sep 16, 2024 @ 11:00 AM BeyondSpring Presents Final Data Analysis of DUBLI... Source: Beyondspring Inc.

Financials
	TTM	Q2 2026	Q1 2026
Basic EPS	$-.17	$-.02	$-.05
Diluted EPS
Revenue	$M	$M	$M
Gross Profit
Net Income / Loss	$-23.11M	$-5.7M	$-6.67M
Operating Income / Loss	$-8.35M	$-1.73M	$-2.23M
Cost of Revenue
Net Cash Flow	$-10.82M	$-3.85M	$-2.96M
PE Ratio